Novavax
stock was climbing Tuesday after the company announced that an initial one million doses of its Covid-19 vaccine are now available for use in the U.K.
Shares of
Novavax
(ticker: NVAX) have struggled this year, tumbling 86% so far in 2022, and 90% in the past 12 months. The company slashed its full-year revenue guidance back in August, and posted a disappointing second quarter amid poor demand for its Covid-19 vaccine.
We came across a bullish thesis on Nu Holdings Ltd. on Global Equity Briefing’s Substack by Ray Myers. In this article,...
The combined market valuation of seven of the top-10 most valued firms eroded by Rs 3,63,412.18 crore last week, with...
The blockchain infrastructure company Fireblocks has struck a deal to buy the crypto accounting platform TRES Finance, company executives told...
This article was written byFollowAn economics graduate with a passion for financial history; I apply my knowledge to markets in...
Cannabis reform’s sworn enemy is claiming credit for the quests to end adult-use marijuana sales in Maine and Massachusetts, where...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
